Yale New Haven Hospital today announced that Thomas Balcezak, MD, MPH has been appointed Chief Medical Officer, effective immediately. Dr. Balcezak was formerly Senior Vice President and Chief Quality Officer for Yale New Haven Hospital, with responsibility for clinical quality, operations improvement, physician credentialing, hospital licensure and accreditation, and program development in the Neurosciences and Medicine Service Lines.
“Dr. Balcezak is eminently qualified for the role of Chief Medical Officer,” said Richard D’Aquila, President of Yale New Haven Hospital and Executive Vice President of Yale New Haven Health System. “He has spent the last 15 years in leadership positions at Yale New Haven Hospital, progressively increasing his responsibilities for performance management, clinical oversight, and medical affairs management.”
As the Chief Medical Officer, Dr. Balcezak will be responsible for all aspects of medical staff affairs administration, graduate medical education, patient safety and clinical quality, accreditation and regulatory readiness, the Hospitalist service, and care management. He will also continue to lead Yale New Haven Health System’s clinical redesign efforts.
A board-certified internist, Dr. Balcezak earned his medical degree from the University of Connecticut and Master’s degree in Public Health from Yale University. He completed his internship and residency training in Internal Medicine at Yale New Haven Hospital, where he also served as Chief Medical Resident. He is an Associate Clinical Professor of Medicine and lecturer in Public Health at the Yale University School of Medicine, Fellow in the American College of Healthcare Executives and American Board of Internal Medicine.
Natives to Connecticut, Dr. Balcezak and his wife Dr. Soni Clubb live in New Haven with their two daughters.
7/10/2026
Yale New Haven Health Heart and Vascular Center honored with 2025 Larry Kraiss Quality Award for excellence in vascular careNew Haven, CT (July 10, 2026)_ Yale New Haven Health Heart and Vascular Center is proud to announce that it has been named a recipient of the 2025 Larry Kraiss Quality Award, a prestigious recognition presented by the Society for Vascular Surgery Patient Safety Organization (SVS-PSO) to hospitals and vascular programs that demonstrate exceptional commitment to improving patient outcomes through collaboration, research, and quality improvement.
7/6/2026
Yale New Haven Hospital Earns the Joint Commission’s Gold Seal of Approval ® for Orthopedic CertificationNew Haven, CT (July 6, 2026) – Yale New Haven Hospital (YNHH) has earned The Joint Commission’s Gold Seal of Approval ® for Orthopedic Certification, a nationally recognized symbol of quality that reflects an organization’s commitment to safe, high-quality patient care. The certification recognizes YNHH’s adherence to rigorous performance standards and evidence-based practices designed to improve patient outcomes and reduce risk.
7/6/2026
Yale New Haven Hospital First in Connecticut to Earn Pregnancy After Loss Clinic CertificationNew Haven, Conn. (July 6, 2026) — Yale New Haven Hospital (YNHH) has become the first hospital in Connecticut to earn certification for its Pregnancy After Loss Clinic through the U.S. Pregnancy After Loss Network, marking a significant advancement in specialized care for patients navigating pregnancy following miscarriage, stillbirth or infant loss.